[Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics].
Makarchuk
P A
PA
D015746:Abdominal Pain / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000328:Adult; D002086:Butylscopolammonium Bromide / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006930:Hyperalgesia / Q000150:complications* / Q000503:physiopathology; D043183:Irritable Bowel Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D010147:Pain Measurement; D017288:Pain Threshold; D010208:Papaverine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014781:Viscera / Q000294:innervation*
D010276:Parasympatholytics; D002086:Butylscopolammonium Bromide; C005317:drotaverin; D010208:Papaverine